Junguo Cao
6PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 04, 2026
Drug screening on tumor organoids exposes therapeutic vulnerabilities of meningiomas to HDAC1/2i panobinostat.Gerhard Jungwirth, Junguo Cao, Yimin Pan
|Oct 25, 2022
Pharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas.Gerhard Jungwirth, Tao Yu, Fang Liu
|Jul 02, 2022
Incidence and survival of benign, borderline, and malignant meningioma patients in the United States from 2004 to 2018.Junguo Cao, Weijia Yan, Guihong Li
|Dec 10, 2021
Receptor-Tyrosine Kinase Inhibitor Ponatinib Inhibits Meningioma Growth In Vitro and In Vivo.Tao Yu, Junguo Cao, Montadar Alaa Eddine
|Jun 01, 2021
Insulin-like Growth Factor 2 mRNA-Binding Protein 2-a Potential Link Between Type 2 Diabetes Mellitus and Cancer.Junguo Cao, Weijia Yan, Xiujian Ma
|May 09, 2018
The Roles of Insulin-Like Growth Factor 2 mRNA-Binding Protein 2 in Cancer and Cancer Stem Cells.Junguo Cao, Qingchun Mu, Haiyan Huang
Pageof 1
Frequent Collaborators
3 joint publications
Mahmoud Moustafa
3 joint publications
Rolf Warta
3 joint publications
Christel Herold-Mende
3 joint publications
Gerhard Jungwirth
2 joint publications
Haiyan Huang
2 joint publications
Montadar Alaa Eddine
2 joint publications
Amir Abdollahi
2 joint publications
Tao Yu
1 joint publications
Qingchun Mu
1 joint publications
Hong Yan
